Issuer · CIK 0001710340

ETON — Eton Pharmaceuticals, Inc.

Recent filings

May 29, 2026·Form 4·Sell$3.8M
ETON/Eton Pharmaceuticals, Inc.
BRYNJELSEN SEAN · President & CEO
48conviction
May 27, 2026·Form 4·Sell$1.2M
ETON/Eton Pharmaceuticals, Inc.
Krempa David · Chief Business Officer
Mechanical filing
AI thesis skipped

← Back to all filings

ETON (Eton Pharmaceuticals, Inc.) — recent insider filings — Form 4 AI